Ole Abildgaard - 01 Aug 2023 Form 3 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
10%+ Owner
Signature
/s/ Ole Abildgaard
Issuer symbol
RENB
Transactions as of
01 Aug 2023
Net transactions value
$0
Form type
3
Filing time
06 Oct 2023, 16:32:46 UTC
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RENB Common Stock 3,462,292 01 Aug 2023 By Paseco ApS
holding RENB Common Stock 5,000 01 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RENB Series A Convertible Preferred Stock 01 Aug 2023 Common Stock 3,436,190 $0.000000 By Paseco ApS F1, F2
holding RENB Warrants (right to buy) 01 Aug 2023 Common Stock 125,000 $1.14 By Paseco ApS F2
holding RENB Warrants (right to buy) 01 Aug 2023 Common Stock 1,415,870 $0.5300 By Paseco ApS F2
holding RENB Warrants (right to buy) 01 Aug 2023 Common Stock 1,718,095 $0.6500 By Paseco ApS F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis and has no expiration date
F2 Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.